The Middle East and Africa respiratory care devices market is expected to grow from US$ 921.48 million in 2022 to US$ 1,381.81 million by 2028; it is estimated to grow at a CAGR of 7.0% from 2022 to 2028.
The advancement in respiratory care devices has increased in the last few years, mainly during the COVID-19 pandemic. During the pandemic, to avoid the infection, demand for home respiratory care products and services increased and led to several innovations in the segment. Additionally, patients' acceptance for out of hospital respiratory care devices created an opportunistic pool for existing market leaders and new players. The emergence of various start-ups and the rise in number of product launches by local and regional players would create growth opportunities for market in the coming years. Key players adopt strategies such as mergers and collaborations to maintain their position in the industry. For instance, in May 2022, Alkem Laboratories launched Innohaler, a dry powder inhaler (DPI) gadget designed to be used by Asthma and COPD patients. This indicates the right opportunity hit by Alkem to address the gap in access to respiratory disease treatment. Moreover, owing to the rising cases of sleep apnea, the positive airway pressure (PAP) devices emerged as the best home care therapeutic devices. Additionally, due to a shortage of ventilators and oxygen cylinders in hospitals, patients preferred ventilators and oxygen therapy at home. As a result, there was a considerable surge in demand for home care respiratory devices, which led to the expansion of the home respiratory therapy industry.
With new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the respiratory care devices market growth at a notable CAGR during the forecast period.
Middle East and Africa Respiratory Care Devices Market Revenue and Forecast to 2028 (US$ Million)
Middle East and Africa Respiratory Care Devices Market Segmentation
The market for Middle East and Africa respiratory care devices market is segmented into product, indication, end user and country. Based on product, the market is segmented into therapeutic devices, monitoring devices, diagnostics devices, and consumables & accessories. The market for the therapeutics devices segment is sub segmented into positive airway pressure (PAP) devices, oxygen concentrator, ventilators, inhalers, nebulizers, humidifiers, and others. The market for the monitoring device segment is sub segmented into pulse oximeters, scenography, and gas analyzers. The market for the diagnostic devices segment is further segmented into spirometers, polysomnography devices, peak flow meters, and other diagnostic devices. The market for the consumables & accessories segment is sub segmented into masks, disposable resuscitators, tracheostomy tubes, breathing circuits, and other consumables and accessories. By indication, the market is segmented into chronic obstructive pulmonary disease (COPD), sleep apnea, asthma, infectious diseases, and others. Based on end user, the Middle East and Africa respiratory care devices market is divided into hospitals, home care, and ambulatory care. Based on country, the Middle East and Africa respiratory care devices market is segmented into South Africa, Saudi Arabia, the UAE, and Rest of Middle East and Africa.
Middle East and Africa Respiratory Care Devices Market—Companies Mentioned
Koninklijke Philips N.V.; ResMed Inc.; Medtronic; Masimo; THERMO FISHER SCIENTIFIC INC; Dragerwerk AG & Co. KGaA; Getinge AB.; Nihon Kohden Corporation; Air Liquide; and Teleflex Incorporated are a few major companies operating in the Middle East and Africa respiratory care devices market.